171 related articles for article (PubMed ID: 31298602)
1. Therapeutic modulation of retinoid X receptors - SAR and therapeutic potential of RXR ligands and recent patents.
Schierle S; Merk D
Expert Opin Ther Pat; 2019 Aug; 29(8):605-621. PubMed ID: 31298602
[No Abstract] [Full Text] [Related]
2. Retinoid X receptor ligands: a patent review (2007 - 2013).
Yamada S; Kakuta H
Expert Opin Ther Pat; 2014 Apr; 24(4):443-52. PubMed ID: 24456080
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of "rexinoids" in cancer prevention and treatment.
Tanaka T; De Luca LM
Cancer Res; 2009 Jun; 69(12):4945-7. PubMed ID: 19509234
[TBL] [Abstract][Full Text] [Related]
4. Structure-Guided Design of a Highly Potent Partial RXR Agonist with Superior Physicochemical Properties.
Lewandowski M; Carmina M; Knümann L; Sai M; Willems S; Kasch T; Pollinger J; Knapp S; Marschner JA; Chaikuad A; Merk D
J Med Chem; 2024 Feb; 67(3):2152-2164. PubMed ID: 38237049
[TBL] [Abstract][Full Text] [Related]
5. Ligand Design for Modulation of RXR Functions.
Martínez C; Souto JA; de Lera AR
Methods Mol Biol; 2019; 2019():51-72. PubMed ID: 31359388
[TBL] [Abstract][Full Text] [Related]
6. Modulation of RXR function through ligand design.
Pérez E; Bourguet W; Gronemeyer H; de Lera AR
Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
[TBL] [Abstract][Full Text] [Related]
7. Methods to Generate an Array of Novel Rexinoids by SAR on a Potent Retinoid X Receptor Agonist: A Case Study with NEt-TMN.
Wagner CE; Jurutka PW
Methods Mol Biol; 2019; 2019():109-121. PubMed ID: 31359392
[TBL] [Abstract][Full Text] [Related]
8. Retinoid X Receptor agonists as selective modulators of the immune system for the treatment of cancer.
Leal AS; Hung PY; Chowdhury AS; Liby KT
Pharmacol Ther; 2023 Dec; 252():108561. PubMed ID: 37952906
[TBL] [Abstract][Full Text] [Related]
9. Retinoid X Receptor Ligands with Anti-Type 2 Diabetic Activity.
Morishita KI; Kakuta H
Curr Top Med Chem; 2017; 17(6):696-707. PubMed ID: 27320332
[TBL] [Abstract][Full Text] [Related]
10. Natural and Structure-based RXR Ligand Scaffolds and Their Functions.
Dominguez M; Alvarez S; de Lera AR
Curr Top Med Chem; 2017; 17(6):631-662. PubMed ID: 27320335
[TBL] [Abstract][Full Text] [Related]
11. Recent Progress in the Design and Discovery of RXR Modulators Targeting Alternate Binding Sites of the Receptor.
Su Y; Zeng Z; Chen Z; Xu D; Zhang W; Zhang XK
Curr Top Med Chem; 2017; 17(6):663-675. PubMed ID: 27320331
[TBL] [Abstract][Full Text] [Related]
12. [Advances in studies on selective RXR ligands].
Mei JH; Wang MW
Yao Xue Xue Bao; 2005 Apr; 40(4):294-8. PubMed ID: 16011254
[No Abstract] [Full Text] [Related]
13. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands.
Crowe DL; Chandraratna RA
Breast Cancer Res; 2004; 6(5):R546-55. PubMed ID: 15318936
[TBL] [Abstract][Full Text] [Related]
14. Modeling, Synthesis, and Biological Evaluation of Potential Retinoid-X-Receptor (RXR) Selective Agonists: Analogs of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahyro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and 6-(Ethyl(4-isobutoxy-3-isopropylphenyl)amino)nicotinic Acid (NEt-4IB).
Jurutka PW; di Martino O; Reshi S; Mallick S; Sabir ZL; Staniszewski LJP; Warda A; Maiorella EL; Minasian A; Davidson J; Ibrahim SJ; Raban S; Haddad D; Khamisi M; Suban SL; Dawson BJ; Candia R; Ziller JW; Lee MY; Liu C; Liu W; Marshall PA; Welch JS; Wagner CE
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830251
[TBL] [Abstract][Full Text] [Related]
15. Alternative retinoid X receptor (RXR) ligands.
Krężel W; Rühl R; de Lera AR
Mol Cell Endocrinol; 2019 Jul; 491():110436. PubMed ID: 31026478
[TBL] [Abstract][Full Text] [Related]
16. Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation.
Pollinger J; Gellrich L; Schierle S; Kilu W; Schmidt J; Kalinowsky L; Ohrndorf J; Kaiser A; Heering J; Proschak E; Merk D
J Med Chem; 2019 Feb; 62(4):2112-2126. PubMed ID: 30702885
[TBL] [Abstract][Full Text] [Related]
17. A Novel Biphenyl-based Chemotype of Retinoid X Receptor Ligands Enables Subtype and Heterodimer Preferences.
Pollinger J; Schierle S; Gellrich L; Ohrndorf J; Kaiser A; Heitel P; Chaikuad A; Knapp S; Merk D
ACS Med Chem Lett; 2019 Sep; 10(9):1346-1352. PubMed ID: 31531208
[TBL] [Abstract][Full Text] [Related]
18. Potential therapeutic uses of rexinoids.
Leal AS; Reich LA; Moerland JA; Zhang D; Liby KT
Adv Pharmacol; 2021; 91():141-183. PubMed ID: 34099107
[TBL] [Abstract][Full Text] [Related]
19. Radioligand binding assay for accurate determination of nuclear retinoid X receptors: A case of triorganotin endocrine disrupting ligands.
Toporova L; Macejova D; Brtko J
Toxicol Lett; 2016 Jul; 254():32-6. PubMed ID: 27153798
[TBL] [Abstract][Full Text] [Related]
20. RAR and RXR modulation in cancer and metabolic disease.
Altucci L; Leibowitz MD; Ogilvie KM; de Lera AR; Gronemeyer H
Nat Rev Drug Discov; 2007 Oct; 6(10):793-810. PubMed ID: 17906642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
